Caudill Cortney bought HALO
February 9, 2026 · Form 4 insider transaction
Caudill Cortney bought 14,047 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,047
Price
$0.00
Total value
N/A
InsiderCaudill Cortney
RoleOfficer
SecurityOption to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after14,047
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests one-fourth on such date and then 1/48th monthly thereafter.